The biomedical community in Scotland has a long-standing record of excellence in cardiovascular research and drug development. Many Scottish clinicians have made a significant worldwide impact in the development of medical practice and four Scottish universities have specialised cardiovascular units within their accompanying hospitals.
Scotland can offer world-class cardiovascular research and development expertise and facilities, first-class contract research services and specialist manufacturing capabilities.
Cardiovascular research excellence
Five Scottish universities and research institutions are active in cardiovascular research, three of which have a 5 or 5 star rating. The British Heart Foundation currently funds 18 Project Grants, totalling £2.23 million, at Scottish Universities.
Key research personnel working to discover and develop cardiovascular drugs, include:
- Dr Gillian A Gray (University of Edinburgh).
- Professor Stuart Malcolm Cobbe (University of Glasgow).
- Professor Keith AA Fox (University of Edinburgh).
- Professor Anna F Dominiczak (University of Glasgow).
- Professor David J Wheatley (University of Glasgow).
- Dr Ian L Megson (University of Edinburgh).
- Professor Jim Shepherd (University of Glasgow).
Cardiovascular research groups and companies in Scotland
Cardiovascular drug research and development is set to grow faster than any other therapeutic area in coming years. Existing research puts Scotland in a good position to capitalise, particularly as the country also offers a favourable regulatory environment, expertise in convergent areas and a first-rate life sciences infrastructure.
Universities and research institutions in Scotland involved in cardiovascular research:
Companies involved in cardiovascular research and drug development in Scotland:
There is a hugely impressive breadth of work being carried out in terms of cardiovascular research and drug development in Scotland. Contact SDI to discover how we can help your company benefit from pioneering cardiovascular work.